Latest News and Events from Sophrosyne

Stay up to date on our products and research.

All Press Releases Publications Corporate Info

Naltrexone Prescribing for AUD Study

Nov 13, 2025|Publications

Overcoming stigma related to AUD

Nov 13, 2025|Publications

Why we should prescribe medications to treat AUD

Nov 13, 2025|Publications

Results from the 2024 National Survey on Drug Use and Health

Nov 11, 2025|Publications

Alcohol Treatment in the United States

Nov 11, 2025|Publications

Few Receive Medications for Alcohol Problems

Nov 11, 2025|Publications

Sophrosyne Pharmaceuticals Announces Formation of Scientific Advisory Board Consisting of Preeminent Key Opinion Leaders

Nov 3, 2025|Press Releases

Sophrosyne Pharmaceuticals Receives FDA Clearance to Initiate Phase 1 Study with its Lead Product for the Treatment of Alcohol Use Disorder (AUD)

Sep 30, 2025|Press Releases

Sophrosyne Pharmaceuticals Appoints Herman Cukier as CEO

Aug 26, 2025|Press Releases

Sophrosyne Corporate Deck

Aug 26, 2025|Corporate Info